AwardedSpainGoods€633,600
Suministro de la vacuna frente al virus respiratorio sincitial Arexvy exclusiva del laboratorio farmacéutico Glaxosmithkline, s.a
- Published
- Published 30 June 2026
Overview
The Servicio Murciano de Salud procured the RSV vaccine Arexvy from pharmaceutical manufacturer GlaxoSmithKline, an exclusive product supply. The contract was awarded to GlaxoSmithKline, S.A. on 27 May 2026 for a value of €1,320,000.
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Estimated value
- €633,600
- Procedure
- Direct
- Published
- 30 June 2026
Vaccines
Award outcome
- Awarded value
- €1,320,000
- Award date
- 27 May 2026
- GLAXOSMITHKLINE, S.A.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
30 June 2026
Contracting authority
Servicio Murciano de Salud - Junta de Compras
Procuring entityEspinardo, Spain
ID_PLATAFORMA: 41261690169929
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.